Home » Sanofi-Aventis US and Intelliject Sign Licensing Agreement
Sanofi-Aventis US and Intelliject Sign Licensing Agreement
Sanofi-aventis U.S. announced Monday the signing of an exclusive licensing
agreement with Intelliject, Inc. for a novel epinephrine auto injector for the emergency treatment of allergic reactions (anaphylaxis) in North America.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May